Detection of genomic aberrations in molecularly defined Burkitt’s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis
暂无分享,去创建一个
R. Spang | W. Klapper | R. Siebert | H. Stein | B. Burkhardt | M. Loeffler | R. Küppers | A. Feller | C. Thorns | M. Hummel | S. Wessendorf | M. Rosolowski | C. Schwaenen | L. Trümper | T. Zenz | M. Kreuz | R. Scholtysik | I. Vater
[1] W. Sanger,et al. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children’s Oncology Group study CCG‐5961 , 2010, British journal of haematology.
[2] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[3] Doron Betel,et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.
[4] P. Dessen,et al. High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's Lymphoma , 2009, PloS one.
[5] J. Nevins,et al. A Role for E2F Activities in Determining the Fate of Myc-Induced Lymphomagenesis , 2009, PLoS genetics.
[6] Y. Asmann,et al. A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer , 2009, Science.
[7] M. Hermiston,et al. CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells , 2009, Immunological reviews.
[8] G. Mills,et al. Uniparental disomy in cancer. , 2009, Trends in molecular medicine.
[9] W. Klapper,et al. GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma , 2009, British journal of haematology.
[10] R. Siebert,et al. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.
[11] S. Nakajima,et al. Human DNA polymerase iota protects cells against oxidative stress , 2008, The EMBO journal.
[12] G. Parmigiani,et al. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers , 2008, Proceedings of the National Academy of Sciences.
[13] L. Staudt,et al. Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt’s lymphoma , 2008, Haematologica.
[14] M. Ziepert,et al. MicroRNA signatures characterize diffuse large B‐cell lymphomas and follicular lymphomas , 2008, British journal of haematology.
[15] R. Spang,et al. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. , 2008, Blood.
[16] Jing Wang,et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.
[17] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[18] H. Tagawa,et al. Synergistic action of the microRNA‐17 polycistron and Myc in aggressive cancer development , 2007, Cancer science.
[19] Vincent De Guire,et al. An E2F/miR-20a Autoregulatory Feedback Loop* , 2007, Journal of Biological Chemistry.
[20] M Loeffler,et al. Development and Implementation of an Analysis Tool for Array-based Comparative Genomic Hybridization , 2007, Methods of Information in Medicine.
[21] R. Spang,et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.
[22] R. Siebert,et al. Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma , 2006, Leukemia.
[23] Wing Hung Wong,et al. Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays , 2006, PLoS Comput. Biol..
[24] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[25] BRLMM : an Improved Genotype Calling Method for the GeneChip ® Human Mapping 500 K Array Set , 2006 .
[26] Shigeru Chiba,et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.
[27] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[28] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[29] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[30] Zhimin Chen,et al. Altered DNA Polymerase ι Expression in Breast Cancer Cells Leads to a Reduction in DNA Replication Fidelity and a Higher Rate of Mutagenesis , 2004, Cancer Research.
[31] R. Siebert,et al. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B‐cell lymphoma with MYC rearrangement , 2004, The Journal of pathology.
[32] Cheng Li,et al. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data , 2004, Bioinform..
[33] Hiroyuki Tagawa,et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. , 2004, Cancer research.
[34] Luc Girard,et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. , 2004, Cancer research.
[35] J. Martinez-Climent,et al. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study , 2003, Leukemia.
[36] A. Sánchez-Aguilera,et al. Cell cycle deregulation in B-cell lymphomas. , 2003, Blood.
[37] J. Weill,et al. Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota , 2002, Nature.
[38] J. Aster,et al. Molecular biology of Burkitt's lymphoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] K. Magnússon,et al. p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. , 1998, Blood.
[40] G. Gaidano,et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.